• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高强度聚焦超声(HIFU)治疗局限性前列腺癌的肿瘤学结局、副作用及合并症。综述。

Oncologic outcome, side effects and comorbidity of high-intensity focused ultrasound (HIFU) for localized prostate cancer. A review.

作者信息

Ziglioli Francesco, Baciarello Marco, Maspero Giada, Bellini Valentina, Bocchialini Tommaso, Cavalieri Domenico, Bignami Elena Giovanna, Maestroni Umberto

机构信息

Department of Urology, University-Hospital of Parma, Via Gramsci, 14, Parma, Italy.

Anesthesia, Intensive Care and Pain Therapy Service, University-Hospital of Parma, Via Gramsci, 14, Parma, Italy.

出版信息

Ann Med Surg (Lond). 2020 May 30;56:110-115. doi: 10.1016/j.amsu.2020.05.029. eCollection 2020 Aug.

DOI:10.1016/j.amsu.2020.05.029
PMID:32637083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7327297/
Abstract

INTRODUCTION

Prostate cancer is considered one of the most important health problems. Due to the increased number of diagnosed patients and the inability to distinguish aggressive tumors, minimally-invasive procedures have become increasingly interesting. High-intensity focused ultrasound (HIFU) is an alternative option to radical surgery to treat prostate cancer. To date, however, data on side effects and comorbidities of this technique are still not conclusive.

METHODS AND RESULTS

We reviewed the literature to concentrate on side effects and comorbidities of HIFU treatment of prostate cancer with the following key words: hifu, high intensity focused ultrasound, ultrasonic therapy, transrectal hifu, prostate ablation, side effects, comorbidities. MedLine and Embase via Ovid database were searched. Selection criteria were: English language, articles published between 2001 and 2015, case series including at least 100 participants and reported data on side effects and comorbidities. Sixteen uncontrolled studies were identified. No randomized controlled trials (RCT) were found in the literature comparing side effects and comorbidities of HIFU to other routine approaches to prostate cancer treatment.

CONCLUSION

HIFU seems to be a promising minimally-invasive treatment for low- and intermediate-risk prostate cancer, especially for patients who are unfit for radical surgery. Prospective studies with longer follow-up periods and RCT are required to properly assess the impact of side effects and comobidities related to the HIFU technique in comparison with other therapies to treat prostate cancer.

摘要

引言

前列腺癌被认为是最重要的健康问题之一。由于确诊患者数量增加以及无法区分侵袭性肿瘤,微创治疗方法变得越来越受关注。高强度聚焦超声(HIFU)是治疗前列腺癌的一种替代根治性手术的选择。然而,迄今为止,关于该技术的副作用和合并症的数据仍不确凿。

方法与结果

我们通过以下关键词检索文献,以聚焦HIFU治疗前列腺癌的副作用和合并症:hifu、高强度聚焦超声、超声治疗、经直肠HIFU、前列腺消融、副作用、合并症。通过Ovid数据库检索了MedLine和Embase。选择标准为:英文文献、2001年至2015年间发表的文章、至少包含100名参与者的病例系列以及报告的副作用和合并症数据。共识别出16项非对照研究。文献中未发现将HIFU与其他常规前列腺癌治疗方法的副作用和合并症进行比较的随机对照试验(RCT)。

结论

HIFU似乎是一种有前景的低危和中危前列腺癌微创治疗方法,尤其适用于不适合根治性手术的患者。需要进行更长随访期的前瞻性研究和RCT,以与其他治疗前列腺癌的方法相比,正确评估与HIFU技术相关的副作用和合并症的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b1c/7327297/e75970c3fce0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b1c/7327297/e75970c3fce0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b1c/7327297/e75970c3fce0/gr1.jpg

相似文献

1
Oncologic outcome, side effects and comorbidity of high-intensity focused ultrasound (HIFU) for localized prostate cancer. A review.高强度聚焦超声(HIFU)治疗局限性前列腺癌的肿瘤学结局、副作用及合并症。综述。
Ann Med Surg (Lond). 2020 May 30;56:110-115. doi: 10.1016/j.amsu.2020.05.029. eCollection 2020 Aug.
2
High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.高强度聚焦超声(HIFU)治疗前列腺癌的确定性方法。
BJU Int. 2012 Nov;110(9):1228-42. doi: 10.1111/j.1464-410X.2012.11262.x. Epub 2012 Jun 6.
3
Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.高强度聚焦超声治疗局限性前列腺癌 14 年的肿瘤学和功能学结果。
BJU Int. 2013 Aug;112(3):322-9. doi: 10.1111/j.1464-410X.2012.11715.x. Epub 2013 Jan 28.
4
High intensity focused ultrasound (HIFU).高强度聚焦超声(HIFU)。
Can J Urol. 2011 Apr;18(2):5634-43.
5
High-Intensity Focused Ultrasound (HIFU) in Localized Prostate Cancer Treatment.高强度聚焦超声(HIFU)在局限性前列腺癌治疗中的应用
Pol J Radiol. 2015 Mar 13;80:131-41. doi: 10.12659/PJR.892341. eCollection 2015.
6
High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Review.高强度聚焦超声治疗前列腺癌:综述
J Endourol. 2017 Apr;31(S1):S30-S37. doi: 10.1089/end.2016.0548. Epub 2017 Mar 29.
7
Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.部分消融与根治性前列腺切除术治疗中危前列腺癌:PART 可行性 RCT。
Health Technol Assess. 2018 Sep;22(52):1-96. doi: 10.3310/hta22520.
8
New treatments for localized prostate cancer.局限性前列腺癌的新疗法。
Urology. 2008 Dec;72(6 Suppl):S36-43. doi: 10.1016/j.urology.2008.08.506.
9
Transrectal-HIFU as primary minimally-invasive option for localized prostate cancer. Is spinal anaesthesia cost-effective? A single centre experience in over 100 patients.经直肠高强度聚焦超声作为局限性前列腺癌的主要微创治疗选择。脊髓麻醉是否具有成本效益?超过100例患者的单中心经验。
Arch Ital Urol Androl. 2009 Mar;81(1):13-6.
10
Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.局限性前列腺癌患者的消融治疗:系统评价与经济学评估
Health Technol Assess. 2015 Jul;19(49):1-490. doi: 10.3310/hta19490.

引用本文的文献

1
Combined therapy of HIFU rectoanal lifting (HIFU-RAL) and sclerotherapy for prolapsed hemorrhoids and rectal mucosal prolapse: A case series.高强度聚焦超声直肠提升术(HIFU-RAL)联合硬化疗法治疗痔脱垂和直肠黏膜脱垂:病例系列
Medicine (Baltimore). 2025 Sep 5;104(36):e44368. doi: 10.1097/MD.0000000000044368.
2
Three-dimensional visualization and navigation for micro-noninvasive uterine fibroid surgery based on MRI and ultrasound image fusion.基于MRI和超声图像融合的微无创子宫肌瘤手术的三维可视化与导航
Front Artif Intell. 2025 Jul 23;8:1613960. doi: 10.3389/frai.2025.1613960. eCollection 2025.
3
Challenges in the diagnosis of primary squamous cell carcinoma of the prostate: a case report and literature review.

本文引用的文献

1
Recurrence of prostate cancer after HIFU. Proposal of a novel predictive index.高强度聚焦超声治疗后前列腺癌的复发。一种新型预测指标的提议。
Acta Biomed. 2018 Jun 7;89(2):220-226. doi: 10.23750/abm.v89i2.6730.
2
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.临床局限性前列腺癌:AUA/ASTRO/SUO 指南。第二部分:推荐方法和特定治疗方案的详细信息。
J Urol. 2018 Apr;199(4):990-997. doi: 10.1016/j.juro.2018.01.002. Epub 2018 Jan 10.
3
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
前列腺原发性鳞状细胞癌诊断中的挑战:一例报告及文献综述
Front Surg. 2025 Jul 17;12:1532669. doi: 10.3389/fsurg.2025.1532669. eCollection 2025.
4
Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study.前列腺癌局部治疗的围手术期并发症:来自德国全国住院患者数据(GRAND)研究的结果
BJU Int. 2025 Aug;136(2):306-313. doi: 10.1111/bju.16746. Epub 2025 Apr 19.
5
Side effects of prostate cancer therapies and potential management.前列腺癌治疗的副作用及潜在管理方法。
J Biol Methods. 2024 Aug 22;11(3):e99010018. doi: 10.14440/jbm.2024.0019. eCollection 2024.
6
Application of combined ablation and immunotherapy in NSCLC and liver cancer: Current status and future prospects.联合消融与免疫疗法在非小细胞肺癌和肝癌中的应用:现状与未来展望
Heliyon. 2024 Aug 14;10(16):e36388. doi: 10.1016/j.heliyon.2024.e36388. eCollection 2024 Aug 30.
7
High-Intensity Focused Ultrasound (Sonablate) for Prostate Cancer: Preliminary Outcomes in Taiwan.高强度聚焦超声(Sonablate)治疗前列腺癌:台湾的初步结果。
Ann Surg Oncol. 2023 Dec;30(13):8764-8769. doi: 10.1245/s10434-023-14250-4. Epub 2023 Sep 11.
8
A review of high-intensity focused ultrasound as a novel and non-invasive interventional radiology technique.高强度聚焦超声作为一种新型非侵入性介入放射学技术的综述。
J Interv Med. 2022 Jun 22;5(3):127-132. doi: 10.1016/j.jimed.2022.06.004. eCollection 2022 Aug.
9
Percutaneous Radiofrequency Ablation (RFA) in renal cancer. How to manage challenging masses. A narrative review.经皮射频消融 (RFA) 治疗肾癌。如何处理具有挑战性的肿块。叙述性综述。
Acta Biomed. 2022 Oct 26;93(5):e2022220. doi: 10.23750/abm.v93i5.12827.
10
Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma.局部区域治疗及其对胰腺导管腺癌肿瘤微环境的影响。
World J Gastroenterol. 2022 Apr 7;28(13):1288-1303. doi: 10.3748/wjg.v28.i13.1288.
AMSTAR 2:一种用于系统评价的关键评估工具,该系统评价包括医疗保健干预措施的随机或非随机研究,或两者皆有。
BMJ. 2017 Sep 21;358:j4008. doi: 10.1136/bmj.j4008.
4
High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Review.高强度聚焦超声治疗前列腺癌:综述
J Endourol. 2017 Apr;31(S1):S30-S37. doi: 10.1089/end.2016.0548. Epub 2017 Mar 29.
5
The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.前列腺癌局部治疗对性功能的影响:三项前瞻性试验的联合分析。
Eur Urol. 2016 May;69(5):844-51. doi: 10.1016/j.eururo.2015.10.030. Epub 2015 Oct 31.
6
Morbidity associated with primary high intensity focused ultrasound and redo high intensity focused ultrasound for localized prostate cancer.原发性高强度聚焦超声和重复高强度聚焦超声治疗局限性前列腺癌的相关发病率。
J Urol. 2014 Jun;191(6):1764-9. doi: 10.1016/j.juro.2013.12.036. Epub 2013 Dec 25.
7
Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.高强度聚焦超声治疗局限性前列腺癌的全腺体消融:1002 例患者的肿瘤学结局和发病率。
Eur Urol. 2014 May;65(5):907-14. doi: 10.1016/j.eururo.2013.04.039. Epub 2013 Apr 30.
8
Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.3 MHz 高强度聚焦超声治疗局限性前列腺癌 15 年的演变和结果。
J Urol. 2013 Aug;190(2):702-10. doi: 10.1016/j.juro.2013.02.010. Epub 2013 Feb 13.
9
Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.高强度聚焦超声治疗局限性前列腺癌 14 年的肿瘤学和功能学结果。
BJU Int. 2013 Aug;112(3):322-9. doi: 10.1111/j.1464-410X.2012.11715.x. Epub 2013 Jan 28.
10
Targeted prostate cancer ablation: energy options.靶向前列腺癌消融术:能量选择。
Curr Opin Urol. 2013 Mar;23(2):123-8. doi: 10.1097/MOU.0b013e32835d9e94.